PodcastIntel
Sign in Get Started Free
BioBoss
BioBoss

Cliff Stocks: Founder and CEO of OncoResponse

Aug 17, 2022 · 34m
✨ AI Summary
  • Cliff Stocks shares leadership insights in biopharma.
  • OncoResponse identifies monoclonal antibodies for cancer therapy.
  • Focus on fully human antibody development.

Guests on This Episode

CS
Cliff Stocks
1 podcast appearance

More from BioBoss

BioBoss
Jun 25, 2026 · 33m
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to BioBoss and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →